University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland
The James Cancer Hospital and Solove Research Institute, Columbus

În curs de recrutareFaza 1/2

Vârste de la 16 la 75 · Toate sexele · Actualizat 10 sept. 2026 · NCT03104491

First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.

Cincinnati Children's Hospital Medical Center, Cincinnati

În curs de recrutareFaza 1

Vârste de 18 ani și peste · Toate sexele · Actualizat 1 sept. 2026 · NCT07586618

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Children's Hospital Medical Center of Akron, Akron
Cincinnati Children's Hospital Medical Center, Cincinnati
Rainbow Babies and Childrens Hospital, Cleveland
și încă 3

În curs de recrutareFaza 1/2

Până la vârsta de 22 · Toate sexele · Actualizat 25 aug. 2026 · NCT04726241

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Cincinnati Children's Hospital Medical Center, Cincinnati

În curs de recrutareFaza 2

Vârste de la 7 la 25 · Toate sexele · Actualizat 19 aug. 2026 · NCT05082519

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

Children's Hospital Medical Center, Cincinnati

În curs de recrutareStudiu observațional

1 Day – 17 Years · Toate sexele · Actualizat 14 aug. 2026 · NCT06274788

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Childrens Hospital Medical Center of Akron, Akron
Cincinnati Children's Hospital, Cincinnati
University Hospitals Case Medical Center, Cleveland
și încă 3

În curs de recrutareStudiu observațional

Toate vârstele · Toate sexele · Actualizat 6 iul. 2026 · NCT01351545

Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase

Cincinnati Children's Hospital Medical Center, Cincinnati

În curs de recrutareFaza 1/2

Până la vârsta de 21 · Toate sexele · Actualizat 3 iun. 2026 · NCT04195347

Genetically Engineered Cells (Anti-CD19/CD20/CD22 CAR T-cells) for the Treatment of Relapsed or Refractory Lymphoid Malignancies

Nationwide Children's Hospital, Columbus
Ohio State University Comprehensive Cancer Center, Columbus

În curs de recrutareFaza 1

Vârste de 2 ani și peste · Toate sexele · Actualizat 29 mai 2026 · NCT05418088

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

Children's Hospital Medical Center of Akron, Akron
Cincinnati Children's Hospital Medical Center, Cincinnati

În curs de recrutareStudiu observațional

Toate vârstele · Toate sexele · Actualizat 18 mai 2026 · NCT01790152

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

Cincinnati Children's Hospital Medical Center, Cincinnati
University of Cincinnati, Cincinnati
The Ohio State University, Columbus

În curs de recrutareFaza 1

Vârste de 13 ani și peste · Toate sexele · Actualizat 5 mai 2026 · NCT04771572

Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide

Ohio State University Medical Center, Columbus

În curs de recrutareFaza 1

Vârste de la 18 la 65 · Toate sexele · Actualizat 25 mar. 2026 · NCT03533816

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

The Ohio State University Comprehensive Cancer Center, Columbus

În curs de recrutareFaza 1/2

Vârste de 12 ani și peste · Toate sexele · Actualizat 24 mar. 2026 · NCT04988555

Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Cleveland Clinic Foundation, Cleveland

În curs de recrutareFaza 2

Vârste de la 18 la 54 · Toate sexele · Actualizat 17 mar. 2026 · NCT06918431

Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL

Cleveland Clinic, Cleveland

În curs de recrutareFaza 1

Vârste de 18 ani și peste · Toate sexele · Actualizat 5 nov. 2025 · NCT04260022

HPC Offered for PRESERVE Expansion

The Ohio State University Medical Center, Columbus

În curs de recrutareStudiu observațional

Vârste de la 12 la 80 · Toate sexele · Actualizat 28 aug. 2025 · NCT07145411

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Cincinnati Children's Hospital Medical Center, Cincinnati
Rainbow Babies, Cleveland
Nationwide Children's Hospital, Columbus

În curs de recrutareFaza 1

Vârste de la 1 la 21 · Toate sexele · Actualizat 6 dec. 2024 · NCT05476770

Sursă: ClinicalTrials.gov, date preluate la 4 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.